{"disease":{"id":"breakthrough-infection","name":"breakthrough infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05020145","title":"COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States","phase":"","overall_status":"COMPLETED","enrollment_count":1277747,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT05222139","title":"Monitoring COVID-19 Vaccination Response in Fragile Populations","phase":"","overall_status":"COMPLETED","enrollment_count":8894,"lead_sponsor_name":"University of Bologna","has_results":false},{"nct_id":"NCT04720144","title":"Breakthrough Invasive Mold Infections Under Posaconazole Prophylaxis (BIMI)","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Centre Hospitalier Universitaire Vaudois","has_results":false},{"nct_id":"NCT05057936","title":"Antibody After COVID-19 Vaccination","phase":"","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"Bangkok Metropolitan Administration Medical College and Vajira Hospital","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}